10x Genomics Inc.

NASDAQ: TXG · Real-Time Price · USD
13.36
0.12 (0.91%)
At close: Aug 15, 2025, 3:45 PM

10x Genomics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
644.47M 624.66M 610.78M 629.74M 631.73M 625.45M 618.73M 590.98M 568.41M 536.2M 516.41M 503.71M 497.93M 499.17M 490.49M 459.18M 405.7M 332.76M
Cost of Revenue
196.59M 194.97M 190.97M 214.82M 227.67M 228.67M 219.13M 178.04M 150.31M 130.8M 120.39M 111.16M 105.3M 82.51M 74.09M 65.39M 55.28M 60.42M
Gross Profit
447.88M 429.69M 419.81M 414.92M 404.06M 396.77M 399.6M 412.94M 418.1M 405.39M 396.02M 392.55M 392.63M 416.66M 416.4M 393.79M 350.42M 272.34M
Operating Income
-100.53M -172.39M -192.46M -178.23M -231.54M -253.16M -245.75M -233.24M -178.44M -178.2M -167.94M -160.68M -136.56M -83.77M -52.25M -446M -495.38M -524.47M
Interest Income
16.95M 17.4M 18.45M 19.06M 18.39M 17.77M 16.91M 15.08M 12.81M 9.95M 6.65M 3.88M 1.91M 725K 206K 218K 197K 264K
Pretax Income
-79.33M -153.4M -177.7M -175.92M -233.22M -256.91M -248.76M -218.58M -166.87M -169.93M -161.97M -161.55M -138.17M -84.29M -53.72M -446.34M -494.96M -524.75M
Net Income
-84.6M -157.04M -182.63M -182.55M -239.78M -264.3M -255.1M -223.36M -172.29M -174.33M -166M -167.23M -142.49M -89.08M -58.22M -455.35M -504.02M -533.14M
Selling & General & Admin
339.69M 348.3M 343.24M 335.54M 336.25M 344.72M 343.33M 336.09M 327.08M 314.9M 298.3M 289.29M 277.97M 267.33M 257.56M 243.66M 233.13M 208.84M
Research & Development
258.61M 260.31M 264.7M 253.28M 295.01M 303.56M 302.02M 310.08M 269.46M 268.69M 265.67M 263.94M 251.23M 233.95M 211.75M 189.57M 165.13M 139.26M
Other Expenses
-9.2M -9.2M 1.66M 1.66M 1.66M 151K -1.5M -1.5M -1.5M n/a -400K -395K -994K -473K -802K -807K 153K -512K
Operating Expenses
589.1M 599.4M 609.6M 590.48M 632.92M 649.94M 645.35M 646.17M 596.54M 583.59M 563.97M 553.23M 529.2M 501.28M 469.31M 433.23M 398.26M 348.11M
Interest Expense
-3K -5K -4K 12K 11K 15K 33K 150K 263K 367K 476K 568K 673K 773K 866K 966K 1.14M 1.24M
Selling & Marketing Expenses
3.9M 3.9M 3.9M 3.3M 3.3M 3.3M 3.3M 3.7M 3.7M 3.7M 3.7M 4.7M 4.7M 4.7M 4.7M 1.9M 1.9M 1.9M
Cost & Expenses
785.69M 797.05M 803.24M 807.97M 863.27M 878.61M 864.48M 824.22M 746.85M 714.39M 684.35M 664.38M 634.49M 583.79M 543.4M 498.62M 453.55M 408.53M
Income Tax Expense
5.27M 3.63M 4.93M 6.63M 6.56M 7.39M 6.34M 4.79M 5.42M 4.4M 4.03M 5.68M 4.33M 4.79M 4.51M 9M 9.06M 8.39M
Shares Outstanding (Basic)
123.76M 122.61M 121.6M 120.73M 120.07M 119.39M 118.57M 117.73M 116.71M 115.62M 114.76M 114.11M 113.57M 112.97M 111.9M 110.87M 109.87M 108.71M
Shares Outstanding (Diluted)
124.51M 122.61M 121.6M 120.73M 120.07M 119.39M 118.57M 117.73M 116.71M 115.62M 114.76M 114.11M 113.57M 112.97M 111.9M 110.87M 109.87M 108.71M
EPS (Basic)
-0.7 -1.3 -1.52 -1.53 -2.02 -2.23 -2.17 -1.91 -1.49 -1.53 -1.47 -1.48 -1.26 -0.79 -0.52 -4.23 -4.73 -5.04
EPS (Diluted)
-0.7 -1.3 -1.52 -1.53 -2.02 -2.23 -2.17 -1.91 -1.49 -1.53 -1.47 -1.48 -1.26 -0.79 -0.52 -4.23 -4.73 -5.04
EBITDA
-54.18M -127.01M -133.99M -131.06M -187.69M -210.4M -205.11M -178.04M -129.52M -135.92M -128.49M -129.13M -106.47M -53.76M -24.59M -419.03M -469.87M -502.28M
EBIT
-79.32M -153.4M -177.7M -175.91M -233.21M -256.9M -248.73M -218.43M -166.6M -169.56M -161.5M -160.99M -137.49M -83.52M -52.85M -445.38M -493.82M -523.51M
Depreciation & Amortization
40.78M 42.03M 43.71M 44.85M 45.52M 46.5M 43.62M 40.38M 37.08M 33.65M 33.01M 31.86M 31.02M 29.76M 28.25M 26.35M 23.95M 21.23M